Want to join the conversation?
Specialty biopharmaceutical company $EBS said that its Board of Directors has authorized the management to implement a stock repurchase program for up to $50MM of common stock from time to time on the open market or in privately negotiated transactions. The term of the authorization of the repurchase program is until Dec. 31, 2017.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)